Name: Reverse Vaccinology: Concept, Methods and Advancement (en Inglés)
Price: 173030.00 CLP
Availability: InStock
Author: Das Jayashankar,Dave Sushma,Soares Siomar De Castro
ISBN: 9780443133954

portada Reverse Vaccinology: Concept, Methods and Advancement (en Inglés)

Reverse Vaccinology: Concept, Methods and Advancement (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Das Jayashankar,Dave Sushma,Soares Siomar De Castro

Idioma

Inglés

N° páginas

382

Encuadernación

Tapa Blanda

ISBN13

9780443133954

N° edición

Reverse Vaccinology: Concept, Methods and Advancement (en Inglés)

Das Jayashankar,Dave Sushma,Soares Siomar De Castro (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 21 días háb.

$ 346.060$ 173.030

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 173.030

Llega entre el 21 Ago y el 27 Ago a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Reverse Vaccinology: Concept, Methods and Advancement (en Inglés)"

Reverse Vaccinology: Concept, Methods, and Advancement presents the development strategy of new vaccines through genome sequencing bioinformatics analysis. This book promises to revolutionize vaccine development, especially for pathogens to which the classical applications of Pasteur's principles have failed, and it is explained in detail in this book. This book is split into three sections: the first, Concept, brings the basis of reverse vaccinology, vaccine antigen discovery, and subunit vaccine; the second, Tools and Methods, describes immunoinformatic, proteomics for epitope-vaccine design, databases, network analysis, machine learning, and NGS-driven antigen screening technology; and the last one, Disease Case Study, discusses real-world examples in the development of new vaccines for diverse diseases. It is a valuable resource for bioinformaticians, researchers, students, and members of the biomedical and medical fields who want to learn more about a new and agile process for the development of new vaccines.